Share
R. Scott Huennekens
QuidelOrtho Corporation, a global leader in in vitro diagnostic technologies for point-of-care settings, clinical labs, and transfusion medicine, has announced the appointment of John R. Chiminski and R. Scott Huennekens as independent directors to its Board of Directors.
These appointments reinforce QuidelOrtho’s dedication to maintaining a strong, independent Board with a diverse mix of expertise and leadership.
R. Scott Huennekens
Mr. Huennekens brings a wealth of experience as a MedTech entrepreneur, CEO, board member, and investor. He was Chair, President, and CEO of Verb Surgical, a surgical technology start-up formed by Google and Johnson & Johnson, from 2015 to 2019. He previously led Volcano Corporation, a leader in interventional cardiology, and Digirad Corporation, a coronary imaging solutions provider. He currently serves as Chair of the boards of Envista Holdings and Hyperfine.
These appointments follow the resignations of James R. Prutow and Robert R. Schmidt, in conjunction with the closing of a secondary stock offering by The Carlyle Group. With the addition of Chiminski and Huennekens, QuidelOrtho’s Board now comprises 11 directors, 10 of whom are independent.
QuidelOrtho remains committed to advancing diagnostics and fostering a healthier future.
Related posts
